A

AeirBio at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

AeirBio takes part in 2 sessions at Cell 2026 in London. Its sessions cover new approaches to treating solid tumours and the path from discovery to deliverable cell and gene therapies. The most distinctive topic is changing the lipid makeup of tumour cell membranes so cancer cells take up more chemotherapy.

OrganizationCell 2026 Attendance
A
AeirBio
Biotech
Memorial Sloan Kettering spin-out developing solid tumour therapies that act on the ceramide and ENT1 pathway to raise chemotherapy uptake.
Talk
Fri Nov 13
12:05pm–12:30pm
Panel
Fri Nov 13
2:45pm–3:10pm
From Discovery To Deliverability: Building The Next Generation Of Cell & Gene Therapies
with NKILT Therapeutics
Cell and gene therapy

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AeirBio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction